Abstract:Shina Song, 1, 2 Xiaofeng Li, 1 Xuting Xue, 3 Wenping Dong, 2 Changxin Li 1 1 Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China; 2 Department of Geriatrics, General Hospital of TISCO, Taiyuan, People's Republic of China; 3 Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, The First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China Correspondence: Wenping Dong, Department of Geriatrics, General Hospital of TISCO, North Street, Xinhualing District, Taiyuan, Shanxi Province, 030009, People's Republic of China, Tel +86 13703581782, Email Changxin Li, Department of Neurology, The First Hospital of Shanxi Medical University, Jiefangnan Road 85, Taiyuan, Shanxi Province, 030001, People's Republic of China, Tel +86 13834635428, Email High temperature requirement A1 (HTRA1) is a member of the serine protease family, comprising four structural domains: IGFBP domain, Kazal domain, protease domain and PDZ domain. HTRA1 encodes a serine protease, a secreted protein that is widely expressed in the vasculature. HTRA1 regulates a wide range of physiological processes through its proteolytic activity, and is also involved in a variety of vascular abnormalities-related diseases. This article reviews the role of HTRA1 in the development of vascular abnormalities-related hereditary cerebral small vessel disease (CSVD), age-related macular degeneration (AMD), tumors and other diseases. Through relevant research advances to understand the role of HTRA1 in regulating signaling pathways or refolding, translocation, degradation of extracellular matrix (ECM) proteins, thus directly or indirectly regulating angiogenesis, vascular remodeling, and playing an important role in vascular homeostasis, further understanding the mechanism of HTRA1's role in vascular abnormality-related diseases is important for HTRA1 to be used as a therapeutic target in related diseases. Keywords: HTRA1, vascular anomalies, cerebral small vessel disease, AMD, tumor High temperature requirement A1 (HTRA1) is a family of highly conserved serine proteases involved in protein quality control. This protein is widely expressed from prokaryotes to eukaryotes and exists in humans as four homologues, HTRA1, HTRA2, HTRA3 and HTRA4. 1 Originally found in E. coli, HTRA1 is an important component of the heat shock response 2,3 and encodes a widely expressed serine protease that is significantly expressed in the vasculature, 1,4 which has both chaperone and serine protease activities and is involved in many physiological processes, particularly extracellular matrix (ECM) remodeling 5–7 and transforming growth factor-β (TGF-β) signaling. 1,8–11 HTRA1 plays an important role in cell proliferation, migration, and apoptosis in addition to controlling protein aggregation through refolding, translocation, or degradation. 12 HTRA1 is commonly expressed in normal human tissues, but at different levels in different tissues and organs, further suggesting that HTRA1 may play different roles in different cell types. HTRA1 genes are associated with cerebral small vessel disease, 13,14 age-related macular degeneration (AMD), 15 multisite tumors, 16–19 arthritis, 20 pre-eclampsia 21 and other microvascular and macrovascular diseases. The pathogenesis is mainly due to impaired vascular function. 22 This review discusses the mechanisms of HTRA1's role in the vasculature and the progress of research on related diseases. Further understanding of the direct or indirect role of HTRA1 in the vasculature may help us to develop HTRA1 as a therapeutic target. Cerebral small vessel disease is a common clinical cerebrovascular disease that can lead to stroke and dementia. 25% of strokes and 45% of dementia are caused by CSVD. Its harmful effects have recently received more and more attention. The clinical manifestations of cerebral small vessel disease are diverse, ranging from asymptomatic to various neurological symptoms, which can cause confusion in diagnosis and treatment. 23 Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL) is a relatively rare hereditary small vessel disease of the brain caused by a homozygous mutation in the HTRA1 gene. The first patient with CARASIL was diagnosed in Japan in 1965, and the clinical manifestations of the disease are mainly cognitive impairment, recurrent strokes, low back pain and hair loss. 24 The pathological changes observed in patients with CARASIL broadly include marked thinning of the outer membrane of small cerebral arteries, massive loss of smoot -Abstract Truncated-

Case Report: Two Unique Nonsense Mutations in HTRA1-related Cerebral Small Vessel Disease in a Chinese Population and Literature Review

Report of Two Pedigrees with Heterozygous HTRA1 Variants‐related Cerebral Small Vessel Disease and Literature Review

Novel Mutations in HTRA1-related Cerebral Small Vessel Disease and Comparison with CADASIL

HTRA1-related autosomal dominant cerebral small vessel disease

Case report: Heterozygous mutation in HTRA1 causing typical cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy

Novel Mutation of HTRA1 Gene Causes Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: One Case

A Frameshift Mutation in HTRA1 Expands CARASIL Syndrome and Peripheral Small Arterial Disease to the Chinese Population

A Family of Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

Reply To: “inappropriate Interpretation of Non‐pathogenic HTRA1 Variant As Pathogenic”

Different phenotypes of moyamoya disease in a Chinese familial case involving heterozygous c.14429G>a variant in RNF213

High-temperature requirement A serine peptidase 1-related cerebral small vessel disease

Compound Heterozygous Mutations in the Neuraminidase 1 Gene in Type 1 Sialidosis: A Case Report and Review of Literature

Report of two Chinese families and a review of Mainland Chinese CADASIL patients.

Case report and literature review: Novel compound heterozygous <i>FIG4</i> variants causing both of peripheral and central nervous system defects

Human Prion Disease with a G114V Mutation and Epidemiological Studies in a Chinese Family: a Case Series

Microbleeds in Heterozygous HTRA1 -Related Cerebral Small Vessel Disease

Case Report: DARS Mutations Responsible for Hypomyelination With Brain Stem and Spinal Cord Involvement and Leg Spasticity

Case report: A novel mutation of RecQ-like helicase 5 in a Chinese family with early myocardial infarction, coronary artery disease, and stroke hemiplegia

A novel heterozygous HTRA1 mutation is associated with autosomal dominant hereditary cerebral small vessel disease

A human induced pluripotent stem cell model from a patient with hereditary cerebral small vessel disease carrying a heterozygous R302Q mutation in HTRA1

Progress in the Study of the Role and Mechanism of HTRA1 in Diseases Related to Vascular Abnormalities